Abstract Guidelines
Abstract submissions open at midday on 31 August 2026 and close at midday on 4 January 2027.
If you are considering submitting an abstract for UK Kidney Week 2027 or another future conference, we recommend taking the time to view our guide to abstract writing, or watch our recent webinar.
Abstract Guidelines
By submitting an abstract, you agree to the following:
- The abstract has appropriate methodology and has the necessary ethical approvals (see link for decision tree: https://www.hra-decisiontools.org.uk/research/)
- The abstract is not an advertisement, nor does it contain anything obscene, defamatory, libellous, unlawful or in any way actionable.
- The abstract will be included on the online conference portal and will be made available on the UK Kidney Week website and UKKA Abstract Archive
- All authors have seen and approved the abstract as submitted.
- The work has not previously been accepted for publication in a peer-reviewed journal.
At least one author must register for the conference and present the work if accepted.
The use of AI tools is permitted and does not disadvantage abstracts in the review process. Authors remain fully responsible for the accuracy, originality, scientific content, interpretation, and integrity of all submitted work. Disclosure is requested solely for transparency. At the point of submission, you will be asked to select which statement is most appropriate to you:
- No AI tools were used in the writing, preparation, analysis, or presentation of this abstract.
- AI tools were used for language support only, such as spelling, grammar, proofreading, translation, or improving clarity and readability. The scientific content, analyses, interpretations, and conclusions are entirely the authors’ own.
- AI tools were used to assist with drafting, editing, or restructuring text based on content provided by the authors. All results, interpretations, and conclusions were generated, reviewed, and verified by the authors.
- AI tools were used to summarise author-generated data, findings, or content for inclusion in the abstract. The underlying data, analyses, and interpretations were created and validated by the authors.
- AI tools were used beyond writing support, for example in data analysis, code generation, figure or image creation, statistical modelling, evidence synthesis, or interpretation of findings.
Please check carefully for typographical errors, misspellings, poor hyphenation, etc. Please check that your abstract title is correct.
Abstract Title
Word count: maximum 25
The ‘Full title’ should be presented in sentence case (not in title case or block capitals), i.e. only the first letter of the title or appropriate terms such as abbreviations or proper nouns should be upper case. The title of the abstract should be clear, precise, engaging, and informative, fully reflecting scope, population, and kidney relevance.
Please do not include author details or information that identifies your unit or hospital in the abstract title.
Authors and Affiliations
You will be asked to provide author and affiliation details within the submission process.
Themes & Keywords
You will be asked to select a broad theme for your abstract, followed by as many relevant keywords as applicable.
Abstract Body
Word count: Maximum 500
Please do not include author details or information that identifies your unit or hospital in the body of the abstract.
The abstract should generally follow this format (although variations in research type may mean alternative sections are used, see below):
| Introduction / Background and Aim
|
The first section should concisely outline the background to the research and why it needed to be undertaken – such as hypothesis testing or a lack of data in a certain area. Include an explicit aim for the study. |
| Methods
|
This section should detail the methods you have used to generate your data. Full details of non-standard abbreviations should be given the first time they are used. |
| Results
|
The next section requires a clear expression of your results. Quantitative data should always be accompanied by the associated unit of measurement (e.g., ng/ml, % of control), where possible. The word ‘significant’ should be used only in association with data assessed for significance (P<0.05) using an appropriate statistical test. The nature of the test can be outlined in the poster/oral.
A figure or table may not be included (see below). Any abstract with any variation of ‘Results expected soon / Results will be presented at UKKW’ will usually be automatically rejected. Ensure that at least some preliminary results are available for markers to assess the quality, impact, and rigour of your work. Descriptions of novel methods or protocols are acceptable, provided they clearly demonstrate strong potential to influence practice, outcomes, policy, service delivery, or future renal research. |
| Discussion | The final section should concisely outline your main findings, either as a summary or a conclusion. Please refrain from stating that further research is necessary. Outline how the work has the potential to influence practice, outcomes, policy, service models, or future renal research, with transferable learning. |
Abstract Themes
You will be able to submit an abstract under one of the following themes, and then you will be able to select as many keywords that are relevant to your submission:
- AKCC
- AKI
- CKD
- Dialysis
- Education
- Glomerular and tubule-interstitial Diseases
- Hypertension and Diabetes
- Physiology, Cell Biology and Genetic Diseases (Basic Science)
- Supportive Care
- Transplant
- Other
Please see the SQUIRE guidelines for QI reporting for more detailed guidance
The abstract should follow this format:
- introduction including a clear aim for the project
- QI methodology used
- results, ideally showing changes in data over time
- discussion – summary of main findings and assessment of how the work can be sustained
The first paragraph should concisely outline why the work was undertaken, for example, the practical implementation of a known or new intervention to improve patient care. It should include a clear project aim.
The second paragraph should concisely outline what you did, for example, team structure, baseline data, QI methodology used, and how progress was measured over time. Measurement may be qualitative (e.g., surveys) or quantitative (numerical). The methods should usually be described in chronological order. Full details of any non-standard abbreviation should be given the first time it is used.
The final section should concisely outline your main findings with reference to the project aim and next steps. The best QI abstracts will often describe the steps taken to ensure the improvement work can be sustained over time, and an assessment of the potential to spread to other healthcare settings.
UKKW will accept case report abstracts for consideration. Case reports that are based on clinico-pathological (kidney biopsy) findings will be eligible for inclusion in the clinic-pathological conference session.
Case Reports should show one or more of the following:
- Unexpected or unusual disease presentations
- Unreported or unusual side effects
- Patient safety considerations
- Findings of relevance to pathogenesis
- Unusual events during treatment or follow-up
- Presentation and management of very rare diseases.
Reports can also comprise:
- N of 1 trials
- Meta-analyses of published case reports
- Retrospective studies that include case-specific information (age, sex and ethnicity)
- Authors are reminded to take particular care to ensure that the submitted case report includes no potential patient identifiers.
For 2027, to align with standard journal-style abstract formats, the submission of figures and tables will not be permitted.
All abstracts must be submitted online using the EventsAir platform.
If all required abstract submission fields have been completed, you will have the option to submit your abstract at the bottom of the page. If there are any remaining fields or sections to complete, you will only have the option to save your submission as a draft until they are completed.
Once you click the ‘submit’ button, the online submission page will change to a submission confirmation page, and you will receive a confirmation email. This may get sent to your junk/spam folder, but if you do not receive it, please email events@ukkidney.org.
You will not be able to edit your submitted abstract, so please do not submit until you are sure all is correct.
Abstract selection will be the responsibility of the Programme Committee, and the submitting author of each abstract will be contacted via the email address given on the submission (unless a different email address is provided)
If such data are available after the regular abstract deadline, the Programme Committee will still consider it for presentation.
Late-breaking abstracts describe the latest advances, trial data, and results that have not been previously published or presented and highlight novel and practice-changing studies.
The call for late-breaking abstracts is NOT an extension of the general submission deadline.
